Myocardial kinetics of iodine-123-BMIPP in canine myocardium after regional ischemia and reperfusion: Implications for clinical SPECT

Journal of Nuclear Medicine

Volumn 38, Issue 12, 1997, Pages 1857-1863

  Hosokawa, Ryohei ^b   Nohara, Ryuji ^a   Fujibayashi, Yasuhisa ^b   Okuda, Kazumi ^b   Ogino, Motonari ^b   Hata, Tatsuhiko ^b   Fujita, Masatoshi ^b   Tamaki, Nagara ^b   Konishi, Junji ^b   Sasayama, Shigetake ^b  

^a KYOTO UNIVERSITY HOSPITAL   (Japan)

^b NONE

Author keywords

Fatty acids; Iodine 123 BMIPP; Ischemic heart disease

Indexed keywords

15 (4 IODOPHENYL) 3 METHYLPENTADECANOIC ACID I 123;

ANIMAL EXPERIMENT; ARTICLE; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; DOSE TIME EFFECT RELATION; DRUG BLOOD LEVEL; DRUG METABOLISM; HEART MUSCLE ISCHEMIA; NONHUMAN; PRIORITY JOURNAL; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY;

ANIMALS; DOGS; FATTY ACIDS; HEART; IODINE RADIOISOTOPES; IODOBENZENES; MALE; MYOCARDIAL ISCHEMIA; MYOCARDIUM; RADIOPHARMACEUTICALS; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON;

EID: 0031461260     PISSN: 01615505     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (28)

1. Knapp FF Jr, Kropp J. Iodine-123-labeled fatty acids for myocardial SPECT: current status and future perspectives. Eur J Nucl Med 1995;22:361-381.
2. Knapp FF Jr, Kropp J, Goodman MM, et al. The development of iodine-123-methyl-branched fatty acids and their applications in nuclear cardiology. Ann Nucl Med 1993;7:1-14.
3. Knapp FF Jr, Goodman MM, Ambrose KR, et al. The development of radioiodinated 3-methyl-branched fatty acids for evaluation of myocardial disease by single photon techniques. In: van der Wall EE, ed. Noninvasive imaging of cardiac metabolism. Dordrecht, The Netherlands: Martius Nijhoff Publishers; 1987:159-201.
4. Fujibayashi, Y, Yonekura Y, Kawai K, et al. Basic studies on I-123-β-methyl-p-iodophenylpentadecanoic acid (BMIPP) for myocardial functional diagnosis: effect of beta-oxidation inhibitor. Jap J Nucl Med 1988;25:1131-1135.
5. Kropp J, Kohler U, Knapp FF Jr, Biersack HJ. 15-(p-[I-123]iodophenyl)-3-R,S-methylpentadecanoic acid to evaluate ischemia in patients with coronary artery disease [Abstract]. Eur J Nucl Med 1991;18(suppl):650.
6. Kropp J, Juergans M, Glaenzer K, et al. Evaluation of ischemia and myocardial viability in patients with coronary artery disease (CAD) with iodine-123-labeled (15-(p-iodophenyl)-3-R,S-methylpentadecanoic acid (BMIPP). Ann Nucl Med 1993; 7:93-100.
7. De Geeter F, Franken PR, Knapp FF Jr, Bossuyt A. Relationship between blood flow and fatty acid metabolism in subacute myocardial infarction: a study by means of Tc-99m-sestamibi and iodine-123-β-methyl iodophenyl-pentadecanoic acid. Eur J Nucl Med 1994;21:283-291.
8. Franken PR, De Geeter F, Dendale P, et al. Abnormal free fatty acid uptake in subacute myocardial infarction after coronary thrombolysis: correlation with wall motion and inotropic reserve. J Nucl Med 1994;35:1758-1765.
9. Tamaki N, Kawamoto M, Yonekura Y, et al. Regional metabolic abnormality in relation to perfusion and wall motion in patients with myocardial infarction: assessment with emission tomography using iodinated branched fatty acid analog. J Nucl Med 1992;33:659-667.
10. Tamaki N, Kawamoto M, Yonekura Y, et al. Assessment of fatty acid metabolism using 1-123 branched fatty acid: comparison with positron emission tomography. Ann Nucl Med 1993;7:41-48.
11. Kawamoto M, Tamaki N, Yonekura Y, et al. Combined study with 1-123 fatty acid and thallium-201 to assess ischemic myocardium: comparison with thallium redistribution and glucose metabolism. Ann Nucl Med 1994;8:847-854.
12. 99mTc-sestamibi. Ann Nucl Med 1995;9:125-130.
13. Yamamichi Y, Kusuoka H, Morishita K, et al. Metabolism of iodine-123-BMIPP in perfused rat hearts. J Nucl Med 1995;36:1043-1050.
14. Fujibayashi Y, Nohara R, Hosokawa R, et al. Metabolism and kinetics of iodine-123-BMIPP in canine myocardium. J Nucl Med 1996;37:757-761.
15. Hosokawa R, Nohara R, Fujibayashi Y, et al. Metabolic fate of Iodine-123 BMIPP in canine myocardium after administration of etomoxir. J Nucl Med 1996;37:1836-1840.
16. Hale SL, Alker KJ, Kloner RA. Evaluation of non-radioactive, colored microspheres for measurement of regional myocardial blood flow in dogs. Circulation 1988;78: 428-434.
17. Hartley CJ, Laston LA, Michael LH, et al. Doppler measurement of myocardial thickening with a single epicardial transducer. Am J Physiol 1983;245:H1066-H1072.
18. Folch J, Lees M. Proteolipides, a new type of tissue lipoproteins. J Biol Chem 1951;191:807-817.
19. Matsunari I, Saga T, Taki J, et al. Kinetics of iodine-123-BMIPP in patients with prior myocardial infarction: assessment with dynamic rest and stress images. Compared with stress thallium-201 SPECT. J Nucl Med 1994;35:1279-1285.
20. Rosamond TL, Abenschein DR, Sobel BE, et al. Metabolic fate of radiolabeled palmitate in ischemic canine myocardium: implications for positron emission tomography. J Nucl Med 1987;28:1322-1329.
21. 18F]fluorodeoxyglucose accumulation during low-flow ischemia: experimental validation [Abstract]. J Nucl Med 1995;36(suppl):4P.
22. Reinhardt CP, Weinstein H, Murcel R, Leppo JA. Comparison of iodine-125-BMIPP and thallium-201 in myocardial hypoperfusion. J Nucl Med 1995;36:1645-1653.
23. Fujibayashi Y, Yonekura Y, Takemura Y, et al. Myocardial accumulation of iodinated beta-methyl-branched fatty acid analog, iodine-125-15-(p-iodophenyl)-3-(R,S)-methylpentadecanoic acid (BMIPP), in relation to ATP concentration. J Nucl Med 1990;31:1818-1822.
24. Nohara R, Okuda K, Hosokawa R, et al. Evaluation of myocardial viability with Iodine-123-BMIPP in a canine model. J Nucl Med 1996;37:1403-1407.
25. Taegtmeyer H, Roberts AFC, Raine AEG. Energy metabolism in perfused heart muscle: metabolic correlates to return of function. J Am Coll Cardiol 1985;6:864-870.
26. Neely JR, Grotyohann LW. Role of glycolytic products in damage to ischemic myocardium: dissociation of adenosine triphosphate levels and recovery of function of reperfused ischemic heart. Circ Res 1984;55:816-824.
27. Nakata T, Hashimoto A, Kobayashi H, et al. Prediction of functional recovery following primary coronary angioplasty with quantitative assessment of myocardial perfusion and fatty acid metabolism [Abstract]. Circulation 1995;92(suppl):I-788-I-789.
28. Nakajima K, Shimizu K, Taki J, et al. Utility of Iodine-123-BMIPP in the diagnosis and follow-up of vasospastic angina. J Nucl Med 1995;36:1934-1940.